Minhao Peng
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Ferroptosis and cancer prognosis 4
- Gallbladder and Bile Duct Disorders 3
- Occupational and environmental lung diseases 2
-
- Hepatocellular Carcinoma Treatment and Prognosis 8
- Co-authors
- Ya Guo (8 shared papers)Wen Zhang (8 shared papers)Banghao Xu (9 shared papers)Dinghua Yang (3 shared papers)Guo‐Qing Jiang (2 shared papers)Tao Peng (12 shared papers)Jingjing Zeng (5 shared papers)Regina M. Santella (4 shared papers)
- Journals
- BioMed Research International (2 papers)Journal of Clinical Oncology (1 paper)World Journal of Surgical Oncology (1 paper)Oncotarget (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Minhao Peng
25 papers receiving 302 citations
Peers
Comparison fields: 5 of 51
- Hepatology 45
- Cancer Research 57
- Oncology 73
- Immunology 36
- Pulmonary and Respiratory Medicine 48
Countries citing papers authored by Minhao Peng
This map shows the geographic impact of Minhao Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minhao Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minhao Peng more than expected).
Fields of papers citing papers by Minhao Peng
This network shows the impact of papers produced by Minhao Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minhao Peng. The network helps show where Minhao Peng may publish in the future.
Co-authors
The 25 scholars most cited alongside Minhao Peng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 43 | |
| 2 | 2019 | 37 | |
| 3 | 2013 | 36 | |
| 4 | Effect of perioperative fluid therapy on early phase prognosis after liver transplantation. | 2008 | 25 |
| 5 | 2009 | 19 | |
| 6 | 2017 | 18 | |
| 7 | 2005 | 17 | |
| 8 | 2021 | 15 | |
| 9 | 2020 | 14 | |
| 10 | 2017 | 12 | |
| 11 | 2016 | 10 | |
| 12 | 2011 | 10 | |
| 13 | Clinical epidemiological study on intrahepatic cholelithiasis: analysis of 8585 cases. | 2003 | 9 |
| 14 | 2006 | 8 | |
| 15 | 2020 | 7 | |
| 16 | 2016 | 6 | |
| 17 | Intrahepatic cholelithiasis in Guangxi area, an analysis of 8585 cases | 2002 | 3 |
| 18 | 2021 | 3 | |
| 19 | 2023 | 3 | |
| 20 | 2019 | 2 |
About Minhao Peng
Minhao Peng is a scholar working on Pulmonary and Respiratory Medicine, Hepatology, Epidemiology, Oncology and Surgery, having authored 28 papers that have together received 304 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Liver Disease Diagnosis and Treatment (5 papers), Ferroptosis and cancer prognosis (4 papers), Hepatitis B Virus Studies (3 papers), Gallbladder and Bile Duct Disorders (3 papers), Organ Transplantation Techniques and Outcomes (3 papers), Occupational and environmental lung diseases (2 papers) and Mycotoxins in Agriculture and Food (2 papers). The work is most often cited by research in Hepatology (45 citations), Cancer Research (57 citations), Oncology (73 citations), Immunology (36 citations) and Pulmonary and Respiratory Medicine (48 citations). Minhao Peng has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Ya Guo, Wen Zhang, Banghao Xu, Dinghua Yang, Guo‐Qing Jiang, Tao Peng, Jingjing Zeng, Regina M. Santella, Kaiyin Xiao and Qiaofei Liu. Their work appears in journals such as BioMed Research International, Journal of Clinical Oncology, World Journal of Surgical Oncology, Oncotarget and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.